Thomas Powles.

TIME100 HealthPioneers Stretching cancer's clockMost people with bladder cancer die within a year, a fact that Thomas Powles, a urologist at Queen Mary University of London, has tried to change for more than two decades. In 2023, he tested a new drug combination: a medication that enhances the immune system's attack on bladder-cancer cells, plus an antibody targeted to those cells and a chemotherapy agent. It more than doubled the median survival of patients, to 2.5 years. "It was beyond my expectations," he says.--A.P.PHOTO (COLOR)By Alice Park; Leslie Dickstein; Sanya Mansoor; Simmone Shah and Julia Zorthian [Extracted from the article]